Výsledky vyhledávání

Akademický článek

A higher blood glucose level pre-breakfast in comparison to bedtime is a contraindication for intensification of prandial insulin therapy in patients with type 2 diabetes – The impact of a negative BeAM value

Autor: Thorsten Siegmund, Anja Borck, Ariel Zisman, Peter Bramlage, Stephan Kress

Publikováno v: Journal of Clinical & Translational Endocrinology, Vol 14, Iss , Pp 34-38 (2018)

Aims: The BeAM value refers to the difference between a patient’s blood glucose level at bedtime (Be) and the following morning before breakfast (AM). The clinical impact of a negative BeAM value (AM blood glucose reading compared to that taken at

Externí odkaz: https://doaj.org/article/f97a60f390d549f89377a62b88525566

Zobrazit plný text záznamu

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose

Autor: Stephan Kress, Peter Bramlage, Ariel Zisman, Thorsten Siegmund, Anja Borck

Publikováno v: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Stephan Kress,1 Anja Borck,2 Ariel Zisman,3 Peter Bramlage,4,5 Thorsten Siegmund6 1Diabeteszentrum, Vinzentius-Krankenhaus, Landau, Germany; 2Medical Department, Sanofi, Berlin, Germany; 3The Endocrine Center of Aventura, Aventura, FL, USA; 4Institut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af84b3bb332a420981b927fcb3a7eb8
http://europepmc.org/articles/PMC7987255

Zobrazit plný text záznamu

Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study

Autor: Martin Pfohl, Thorsten Siegmund, Peter Bramlage, Jochen Seufert, Anja Borck

Publikováno v: Diabetes Therapy

Introduction The IGLU-S study assessed the effectiveness of insulin glulisine after switching from human insulin/other rapid-acting insulin analogues in patients with type 1 diabetes (T1DM) and type 2 diabetes (T2DM) in a real-world setting in German

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5440a3239965436d02df033948aae4a
https://doi.org/10.1007/s13300-021-00999-y

Zobrazit plný text záznamu

Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study

Autor: Martin Pfohl, Anja Borck, Peter Bramlage, Jochen Seufert, Thorsten Siegmund

Publikováno v: Diabetes Therapy

Introduction The IGLU-SIT study documented the effectiveness of initiating supplementary prandial insulin treatment (SIT) with insulin glulisine after failure of oral antidiabetic drugs alone in patients with type 2 diabetes (T2DM) in a real-world se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53142d2143d0fed67c978aa0f0e67eb2
http://europepmc.org/articles/PMC7947113

Zobrazit plný text záznamu

Wann mit der intensivierten Insulintherapie beginnen? – Der BeAM-Wert zur besseren Abschätzung einer prandialen Insulintherapie bei Typ-2-Diabetes mellitus

Autor: Thorsten Siegmund, Anja Borck, Ariel Zisman, Stephan Kress, Peter Bramlage

Publikováno v: Diabetes aktuell. 18:69-76

ZUSAMMENFASSUNGDer BeAM-Wert ist ein kumulatives Maß der postprandialen Hyperglykämie. Er lässt sich aus der Blutglukosekonzentration vor dem Zubettgehen (Be) und der darauf folgenden Nüchternglukose am Morgen (AM) errechnen. In zwei retrospektiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9e1691c7beca944018009a5e779793fc
https://doi.org/10.1055/a-1145-4047

Zobrazit plný text záznamu

Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world study

Autor: Helmut Anderten, Anja Borck, Katrin Pegelow, Stefan Pscherer, Peter Bramlage, Andreas Fritsche, Jochen Seufert, Martin Pfohl

Publikováno v: Acta Diabetologica. 57:89-99

Adequate insulin titration is crucial for optimal glycaemic control in type 2 diabetes (T2D). We aimed to explore the factors and outcomes associated with titration of glargine 100 U/mL (Gla-100) in patients uncontrolled on oral antidiabetic drugs (O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6c8da94fe9d1a61a88f6a1e6406e690
https://doi.org/10.1007/s00592-019-01383-w

Zobrazit plný text záznamu

Wann mit der intensivierten Insulintherapie beginnen? – Der BeAM-Wert zur besseren Abschätzung einer prandialen Insulintherapie bei Typ-2-Diabetes mellitus

Autor: Peter Bramlage, Stephan Kress, Ariel Zisman, Thorsten Siegmund, Anja Borck

Publikováno v: Diabetologie und Stoffwechsel. 14:302-309

ZusammenfassungDer BeAM-Wert ist ein kumulatives Maß der postprandialen Hyperglykämie. Er lässt sich aus der Blutglukosekonzentration vor dem Zubettgehen (Be) und der darauf folgenden Nüchternglukose am Morgen (AM) errechnen. In zwei retrospektiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::032850bd0418b0214265aab3e3f9694a
https://doi.org/10.1055/a-0958-2034

Zobrazit plný text záznamu

Predictors of treatment response in type‐2 diabetes patients initiating basal‐supported oral therapy with insulin glargine 100 U/mL: A sub‐analysis of the Titration and OPtimisation (TOP) registry

Autor: Jochen Seufert, Martin Pfohl, Katrin Pegelow, Peter Bramlage, Andreas Fritsche, Stefan Pscherer, Helmut Anderten, Anja Borck

Publikováno v: Diabetes, Obesity and Metabolism. 21:2169-2173

The aim of this study was to identify predictors of long-term response to the initiation of basal-supported oral therapy (BOT) with insulin glargine (IGlar-100). Patients from the observational TOP registry were grouped based on those who had achieve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6033a9d71ff49fa3e66759b5e943e820
https://doi.org/10.1111/dom.13768

Zobrazit plný text záznamu

Autor: Peter Bramlage, Stephan Kress, Anja Borck, Ariel Zisman, Thorsten Siegmund

Publikováno v: Journal of Clinical & Translational Endocrinology, Vol 14, Iss, Pp 34-38 (2018)
Journal of Clinical & Translational Endocrinology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4cc5a4573d5d330b741949a43ddb95
http://www.sciencedirect.com/science/article/pii/S2214623718301066

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání